BioLineRx Announces $3.75 Million Fundraising via Direct Offering
BioLineRx (BLRX) has announced a registered direct offering and concurrent private placement aimed at raising approximately $3.75 million in gross proceeds. The company plans to issue 1.35 million American Depositary Shares (ADSs), each priced at $2.78, along with new warrants for up to an additional 2.02 million ADSs exercisable at the same price. This fundraising effort is intended to support ongoing operations and development initiatives within the company's pipeline of therapeutic candidates. The offering highlights BioLineRx’s strategy to secure capital through a combination of equity issuance and warrant financing, which could provide flexibility for future growth or clinical advancements.
Tickers: $BLRX
Topics: capital raise private placement registered direct offering